非肌层浸润性膀胱癌指南依从性:全球3595名参与者调查
该国际调查评估了全球泌尿外科医生对非肌层浸润性膀胱癌(NMIBC)指南的实施与依从性。3595名泌尿外科医生参与,其中2319人提供了对EAU、AUA等指南的依从信息。结果显示EAU指南最受青睐,但总体依从性不一致且存在地区差异。
要点
- EAU指南在NMIBC诊疗中最常被遵循(40%),其次为改编自AUA/EAU的国家指南(31%)。
- 膀胱活检时指南遵循率为42-70%,总体依从性不一致且地区差异明显。
- 多数受访者每月经尿道膀胱肿瘤电切术少于5例,且仅17%为泌尿肿瘤专科医生。
核心结论
- EAU指南在各大洲NMIBC诊疗中最受偏好,但总体指南依从性不一致且地区间差异显著。
- 鉴于指南提供最佳循证知识,建议在日常临床实践中更一致地遵循指南。
研究设计与样本
- 国际跨语言问卷调查,面向SIU成员,评估NMIBC诊断治疗实践及指南依从性。
- 共3595名泌尿外科医生参与,其中2319人提供了对EAU、AUA及其他国家指南的依从信息。
- 受访者92%为男性,超过50%临床实践超过15年;57%为普通泌尿外科,17%为泌尿肿瘤专科医生,8%为腔内泌尿外科医生。
- 多数在学术机构执业,60%每月经尿道膀胱肿瘤电切术少于5例。
主要发现
- 膀胱活检时指南遵循率为42-70%。
- 40%遵循EAU指南,31%遵循改编自AUA/EAU等的国家指南,14%遵循本国学会指南。
临床怎么用
- 临床实践中应更一致地遵循EAU等循证指南进行NMIBC诊疗。
- 应关注不同地区间指南依从性的差异,针对性改进。
局限性
- 美洲参与度低可能限制研究结果在该地区的适用性。
- 未来研究应纳入更多样化的北美样本以提高普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the implementation and adherence of (inter)national guidelines (GLs) on non-muscle-invasive bladder cancer (NMIBC) across continents. SUBJECTS AND METHODS: An international, inter-lingual survey was designed to capture the practice of diagnosis and treatment of NMIBC globally, including questions designed to evaluate compliance to GLs. An invitation was sent to members of the Société Internationale d'Urologie (SIU). We assessed the adherence to GLs in relation to age, working environment, subspecialities, gender, and years of experience. RESULTS: A total of 3595 urologists took part in the survey and 2319 provided information about their compliance to European Association of Urology (EAU), American Urological Association (AUA), and other (inter)national GLs. The survey comprised 92% males including >50% in clinical practice for >15 years; 57% were in general practice, whereas 17% were qualified uro-oncologist and 8% endourologist. The majority were in academic practice and most (60%) performed <5 transurethral resection of bladder tumour/month. GLs were followed in 42-70% of cases when taking bladder biopsies. The majority followed the EAU GLs (40%) followed by national GLs modified from the AUA, EAU or similar GLs (31%), or national GLs by their own societies (14%). Low participation from the Americas may limit the applicability of findings to that region; future studies should engage more diverse North American samples to enhance generalisability. CONCLUSION: The EAU GLs were mostly preferred in NMIBC diagnosis and treatment across all continents. General adherence to the GLs was inconsistent, with notable variances among the different regions. As GLs provide the best evidence-based knowledge, it is advised to adhere to them more consistently in daily clinical practice.
引用
- Abdulmajeed A, Bekiroglu F, Aydin A, et al. Guidelines adherence in non-muscle-invasive bladder cancer: a global survey of 3595 participants. BJU Int. 2025. PMID: 41254871. doi:10.1111/bju.70079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。